Pharmalot... Pharmalittle... Good Morning

Hello, everyone, and welcome to yet another steamy summer day. Despite the heat, we are persevering by fortifying ourselves with a few cups of stimulation and our trusty cooling unit. After all, there is much to be done and we trust you can relate. So no time like the present. Here are some tidbits to get you going. Hope your day goes well and you stay cool. And as always, do stay in touch. We are happy to accept classified information... J&J Raises Forecast And Reports Strong Earnings (Bloomberg News) FDA Postpones Meeting For Merck Anesthesia Drug (Bloomberg News) First Manhattan Sues Vivus For Delaying Shareholder Meeting (Reuters) Ex-Im Bank Of India To Offer Loans To GMP Compliant Factories (LiveMint) Five More Countries Approve Pfizer Xeljanz Arthritis Pill (Associated Press) UK's NICE Rejects Pfizer Drug For Bone Cancer (Reuters) Merck Reports Positive Data For Its Bace Inhibitor Alzheimer's Med (PM Live) Roche To Spend $105M On Swiss Training Center (Reuters) ...Read more
Source: Pharmalot - Category: Pharma Commentators Authors: Source Type: blogs